Salovum and Its Effect on Pressure and Inflammation in Glioblastoma
Tests Salovum, an egg yolk powder, in adults having biopsies for suspected glioblastoma.
Plain-language title generated from the registry record
Registry title: Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
Key facts
- Where
- Lund, SwedenSee the site
- Phase
- Phase 2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07364786, who can take part
Where in Sweden
- Department of Neurosurgery, Skane University HospitalLund, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peter Siesjö
- Trial code
- NCT07364786
- Record updated
- 23 January 2026
- Original description
The objective of this clinical trial is to investigate the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, in participants undergoing diagnostic biopsies for suspected glioblastoma. The primary questions the trial seeks to answer are:Read full original descriptionShow less
Intratumoral Pressure, Intratumoral Partial Oxygen Pressure, and Inflammatory Cytokines in Antisecretory Factor Treatment of Glioblastoma
The objective of this clinical trial is to investigate the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, in participants undergoing diagnostic biopsies for suspected glioblastoma. The primary questions the trial seeks to answer are:
* Will Salovum® reduce intratumoral pressure? * Will Salovum® influence the release of inflammatory cytokines from tumor tissue? Additionally, the study will investigate the impact of Salovum® on intratumoral partial oxygen pressure and tumor volume.
Researchers will:
* Place probes for measuring intratumoral pressure, microdialysis, and partial oxygen pressure during a standard biopsy procedure. * Compare measurements from participants before and during ingestion of Salovum®.
Participants will:
* Have probes implanted during a surgical biopsy. * Ingest Salovum® 24 to 72 hours after the procedure.
Inclusion: Suspected glioblastoma; Age 18-75 years; Planned diagnostic biopsy; Informed consent of subject.
Exclusion: Known egg yolk allergy.